0001209191-22-011731.txt : 20220222
0001209191-22-011731.hdr.sgml : 20220222
20220222165933
ACCESSION NUMBER: 0001209191-22-011731
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220214
FILED AS OF DATE: 20220222
DATE AS OF CHANGE: 20220222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ehrlich Christopher B
CENTRAL INDEX KEY: 0001293973
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39866
FILM NUMBER: 22659113
MAIL ADDRESS:
STREET 1: 499 ILLINOIS STREET, SUITE 200
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: eFFECTOR Therapeutics, Inc.
CENTRAL INDEX KEY: 0001828522
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 853306396
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 142 NORTH CEDROS AVENUE, SUITE B
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
BUSINESS PHONE: (858) 925-8215
MAIL ADDRESS:
STREET 1: 142 NORTH CEDROS AVENUE, SUITE B
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
FORMER COMPANY:
FORMER CONFORMED NAME: Locust Walk Acquisition Corp.
DATE OF NAME CHANGE: 20201015
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-14
0
0001828522
eFFECTOR Therapeutics, Inc.
EFTR
0001293973
Ehrlich Christopher B
C/O EFFECTOR THERAPEUTICS, INC.
142 NORTH CEDROS AVENUE, SUITE B
SOLANA BEACH
CA
92075
1
0
0
0
Common Stock
2022-02-14
4
P
0
2000
4.45
A
15000
D
Common Stock
2022-02-18
4
P
0
1000
4.30
A
16000
D
Common Stock
142168
I
By Locust Walk Partners LLC
Common Stock
1034
I
By Locust Walk Partners LLC
The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at prices ranging from $4.40 to $4.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person.
Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse.
/s/ Michael Byrnes, Attorney-in-Fact for Christopher B. Ehrlich
2022-02-22